Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

A tumor-specific stem cell

Cancer stem cells are thought to share many characteristics with their normal stem cell counterparts, raising concerns about the ability to selectively target them. A new study shows that Dclk1 marks cancer, but not normal, stem cells in the intestine and that targeting this population results in adenoma collapse without affecting normal tissue.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Intestinal CSCs are distinct from NSCs.

References

  1. Clevers, H. Nat. Med. 17, 313–319 (2011).

    Article  CAS  Google Scholar 

  2. Nakanishi, Y. et al. Nat. Genet. 45, 98–103 (2013).

    Article  CAS  Google Scholar 

  3. May, R. et al. Stem Cells 26, 630–637 (2008).

    Article  Google Scholar 

  4. Gerbe, F., Brulin, B., Makrini, L., Legraverend, C. & Jay, P. Gastroenterology 137, 2179–2180 (2009).

    Article  CAS  Google Scholar 

  5. Barker, N. et al. Nature 449, 1003–1007 (2007).

    Article  CAS  Google Scholar 

  6. Schepers, A. G. et al. Science 337, 730–735 (2012).

    Article  CAS  Google Scholar 

  7. Polakis, P. Curr. Opin. Pharmacol. 5, 382–387 (2005).

    Article  CAS  Google Scholar 

  8. Tian, H. et al. Nature 478, 255–259 (2011).

    Article  CAS  Google Scholar 

  9. Chen, J. et al. Nature 488, 522–526 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frederic J de Sauvage.

Ethics declarations

Competing interests

The authors are employees of Genentech, Inc., and F.J.d.S. owns shares of Roche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Metcalfe, C., de Sauvage, F. A tumor-specific stem cell. Nat Genet 45, 7–9 (2013). https://doi.org/10.1038/ng.2502

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.2502

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer